What would be the recommended induction of anesthesia for a male patient undergoing PPV/Vitrectomy with a planned regimen of Sevoflurane, Target-Controlled Infusion (TCI) remifentanil, and Atracurium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Induction Protocol for PPV/Vitrectomy with Sevoflurane-TCI Remifentanil-Atracurium

For a hemodialysis patient undergoing vitrectomy with your planned regimen, induce with sevoflurane 8% via vital capacity technique OR propofol 2 mg/kg IV, followed immediately by remifentanil 1 mcg/kg over 30-60 seconds, then atracurium 0.5 mg/kg once loss of consciousness is achieved. 1, 2

Specific Induction Sequence

Pre-Induction Preparation

  • Establish two large-bore IV lines before induction, as vascular access may be challenging in HD patients 3
  • Set up invasive arterial blood pressure monitoring before induction when feasible, with transducer at tragus level 2, 4
  • Have vasopressors immediately available (ephedrine 5-10 mg or metaraminol 0.5-1 mg boluses) as propofol causes dose-dependent cardiovascular depression 2, 4
  • Apply BIS or entropy monitoring targeting 40-60 to prevent awareness 2, 4

Induction Options

Option 1: Sevoflurane Vital Capacity Induction (Preferred for hemodynamic stability)

  • Administer 8% sevoflurane in 75% N₂O/O₂ from a primed circuit via vital capacity technique 5
  • Loss of consciousness occurs in 39 seconds (59% in one breath) 5
  • Once unresponsive, give remifentanil 1 mcg/kg IV over 30-60 seconds 1
  • After 2-3 minutes, administer atracurium 0.5 mg/kg IV 3
  • Intubate after 3-4 minutes total 6

Option 2: Propofol IV Induction

  • Administer propofol 2 mg/kg IV bolus (reduce dose by 25-30% in elderly or hemodynamically unstable patients) 1, 2
  • Simultaneously or immediately after, give remifentanil 1 mcg/kg over 30-60 seconds 1
  • Once loss of consciousness confirmed, give atracurium 0.5 mg/kg IV 3
  • Intubate after 3-4 minutes 6

Critical Dosing Considerations

Remifentanil Dosing Strategy

  • The 1 mcg/kg dose provides acceptable intubation conditions with 10% incidence of respiratory depression 7
  • Avoid higher doses (2-4 mcg/kg) as they cause significant hypotension and prolonged apnea 7
  • If intubation occurs >8 minutes after starting remifentanil, use infusion at 0.5-1 mcg/kg/min instead of bolus 1

Atracurium Selection Rationale

  • Atracurium is ideal for HD patients as metabolism is independent of kidney function (Hofmann elimination and ester hydrolysis) 3
  • Dose: 0.5 mg/kg IV for intubation 3
  • Avoid rocuronium or vecuronium in HD patients due to renal elimination concerns

Sevoflurane Considerations

  • MAC for sevoflurane is 2.1% at age 40, decreases with age 8
  • Use 8% for induction, then reduce to 1.7% for maintenance 9, 10
  • Provides faster induction than propofol (39 vs 252 seconds to loss of consciousness) 5
  • Better hemodynamic stability during induction compared to propofol 6, 11

Maintenance Transition

Once intubated, immediately transition to:

  • Sevoflurane 1.7% end-tidal concentration 10
  • Remifentanil TCI at effect-site concentration 1-3 ng/mL (start at 0.05-0.3 mcg/kg/min infusion) 2, 7
  • Do NOT give additional atracurium boluses - single intubating dose only, as neuromuscular blockade interferes with depth monitoring 4
  • Maintain BIS 40-60 throughout 2, 4

Critical Pitfalls to Avoid

  • Never use propofol boluses during maintenance - causes hemodynamic instability; use continuous infusion only if switching from sevoflurane 2
  • Never give remifentanil as bolus during maintenance - causes respiratory depression; use continuous TCI infusion only 2, 7
  • Avoid rocuronium in HD patients - renal elimination makes it unsuitable 3
  • Do not assume adequate depth without monitoring - use BIS/entropy to prevent awareness, especially important as sevoflurane-remifentanil has lower awareness risk than TIVA alone 3, 2
  • Have rescue hydrocortisone 100 mg IV available - unexplained intraoperative hypotension in any patient may indicate adrenal crisis 3

Hemodynamic Management

  • Target mean arterial pressure >65 mmHg 4
  • Treat hypotension with vasopressors (ephedrine or metaraminol) rather than excessive fluids 4
  • Expect heart rate to remain stable or slightly elevated with sevoflurane (more so than propofol) 6, 11
  • Blood pressure typically decreases 10-20% after induction with either technique 6, 5

Special Considerations for HD Patients

  • HD patients are considered "frail" with increased complication risk 3
  • Assume some degree of volume status abnormality - have vasopressors ready but avoid excessive fluid administration 4
  • Monitor for electrolyte abnormalities (especially potassium) that may affect cardiac stability 3
  • Consider reduced propofol dose if using IV induction due to altered pharmacokinetics 2

References

Guideline

Guidelines for Total Intravenous Anesthesia (TIVA) with Target-Controlled Infusion (TCI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anesthetic Management for Spine Surgery with Intraoperative Neuromonitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Remifentanil Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.